What is the current Price Target for the Revolution Medicines Inc stock?

The average Revolution Medicines Inc target price is $72.33. This is 120.06% higher than the current stock price. The highest price target is 164.68%, the lowest is 79.49%. 12 Analysts have issued a price target Revolution Medicines Inc 2026 .

How high will the Revolution Medicines Inc stock rise?

No reliable answer can be given as to how high the Revolution Medicines Inc stock will rise. The performance of stocks, including the Revolution Medicines Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Revolution Medicines Inc stock today?

The performance of Revolution Medicines Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Revolution Medicines Inc stock fall?

The decline in Revolution Medicines Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Revolution Medicines Inc Forecast, price target & analysts

$31.28

4.84% today

Nasdaq, Apr 04, 07:49 pm CET

ISIN

US76155X1000

Symbol

RVMD

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Revolution Medicines Inc Target price 2025 - Analyst rating & recommendation

Revolution Medicines Inc Classifications & Recommendation:

Buy

100%

Revolution Medicines Inc Price Target

Target Price	$72.33
Price	$32.87
Potential	120.06% register free of charge
Number of Estimates	12

	12 Analysts have issued a price target Revolution Medicines Inc 2026 . The average Revolution Medicines Inc target price is $72.33. This is 120.06% register free of charge higher than the current stock price. The highest price target is $87.00 164.68% register free of charge , the lowest is $59.00 79.49% register free of charge .
	A rating was issued by 13 analysts: 13 Analysts recommend Revolution Medicines Inc to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Revolution Medicines Inc stock has an average upside potential 2026 of 120.06% register free of charge . Most analysts recommend the Revolution Medicines Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-3.58	-4.67
	7.25%	30.45%
P/E		negative
EV/Sales		584.63

8 Analysts have issued a Revolution Medicines Inc forecast for earnings per share. The average Revolution Medicines Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-3.58	7.25%
2025	$-4.67 30.45% Unlock
2026	$-5.10 9.21% Unlock
2027	$-4.44 12.94% Unlock
2028	$-2.89 34.91% Unlock
2029	$0.20 106.92% Unlock

Current	-9.21	7.85%
2025	-7.03 23.67% Unlock
2026	-6.45 8.25% Unlock
2027	-7.40 14.73% Unlock
2028	-11.36 53.51% Unlock
2029	161.66 1,523.06% Unlock

Revolution Medicines Inc...

Current Revolution Medicines Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Stifel	Locked ➜ Locked	Locked	Apr 01 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 03 2025
Needham	Locked ➜ Locked	Locked	Feb 27 2025
Stifel	Locked ➜ Locked	Locked	Feb 27 2025
UBS	Locked ➜ Locked	Locked	Jan 08 2025
Needham	Locked ➜ Locked	Locked	Dec 06 2024
Wedbush	Locked ➜ Locked	Locked	Dec 06 2024

Analyst Rating	Date
Locked Stifel: Locked ➜ Locked	Apr 01 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 03 2025
Locked Needham: Locked ➜ Locked	Feb 27 2025
Locked Stifel: Locked ➜ Locked	Feb 27 2025
Locked UBS: Locked ➜ Locked	Jan 08 2025
Locked Needham: Locked ➜ Locked	Dec 06 2024
Locked Wedbush: Locked ➜ Locked	Dec 06 2024

Discover more stocks with a high price target

Novo Nordisk 83.92%

Coinbase Global, Inc. 83.53%

BioNTech SE - ADR 50.09%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now